MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welsby, P. J.
Right arrow Articles by Milligan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welsby, P. J.
Right arrow Articles by Milligan, G.

Vol. 61, Issue 5, 1211-1221, May 2002

Enhanced Detection of Receptor Constitutive Activity in the Presence of Regulators of G Protein Signaling: Applications to the Detection and Analysis of Inverse Agonists and Low-Efficacy Partial Agonists

Philip J. Welsby, Elaine Kellett, Graeme Wilkinson, and Graeme Milligan

Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom (P.J.W., E.K., G.M.); and Molecular Pharmacology and Biochemistry, Department of Enabling Science and Technology, Astra-Zeneca, Alderley Park, Macclesfield, Cheshire, England, United Kingdom (G.W.)

Fusion proteins between the human 5-hydroxytryptamine (5-HT)1A receptor and either wild type or certain pertussis toxin-resistant forms of Go1alpha and Gi1alpha display constitutive GTPase activity that can be inhibited by the inverse agonist spiperone. Addition of recombinant regulator of G protein signaling (RGS) 1 or RGS16 to membranes expressing these fusion proteins resulted in elevation of this constitutive GTPase activity without significantly altering the binding affinity of antagonist/inverse agonist ligands. For a 5-HT1A receptor-(Cys351Ile)Go1alpha fusion protein the increase in basal GTPase activity was greater than 4-fold. Enzyme kinetic analysis demonstrated that the effect of RGS1 was as a GTPase-activating protein for the fusion construct. In the presence of the RGS proteins, both agonists and inverse agonists produced much more robust regulation of high-affinity GTPase activity than in their absence. This allowed detection of the partial agonist nature of WAY100635, which has been described previously as a neutral antagonist at the 5-HT1A receptor. Of a range of ligands studied, only haloperidol functioned as a neutral ligand in the presence of RGS1. These studies show that addition of a recombinant RGS protein provides a simple and novel means to elevate the fraction of basal membrane GTPase activity contributed by the constitutive activity of a receptor. By so doing, it also greatly enhances the ability to detect and analyze the effects of inverse agonists and to discriminate between neutral ligands and those with low levels of positive intrinsic efficacy.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. J. Clark, J. J. Linderman, and J. R. Traynor
Endogenous Regulators of G Protein Signaling Differentially Modulate Full and Partial {micro}-Opioid Agonists at Adenylyl Cyclase as Predicted by a Collision Coupling Model
Mol. Pharmacol., May 1, 2008; 73(5): 1538 - 1548.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Milligan
Constitutive Activity and Inverse Agonists of G Protein-Coupled Receptors: a Current Perspective
Mol. Pharmacol., December 1, 2003; 64(6): 1271 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Osterhout, A. A. Waheed, A. Hiol, R. J. Ward, P. C. Davey, L. Nini, J. Wang, G. Milligan, T. L. Z. Jones, and K. M. Druey
Palmitoylation Regulates Regulator of G-protein Signaling (RGS) 16 Function: II. PALMITOYLATION OF A CYSTEINE RESIDUE IN THE RGS BOX IS CRITICAL FOR RGS16 GTPase ACCELERATING ACTIVITY AND REGULATION OF Gi-COUPLED SIGNALING
J. Biol. Chem., May 23, 2003; 278(21): 19309 - 19316.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Newman-Tancredi, D. Cussac, L. Marini, and M. J. Millan
Antibody Capture Assay Reveals Bell-Shaped Concentration-Response Isotherms for h5-HT1A Receptor-Mediated Galpha i3 Activation: Conformational Selection by High-Efficacy Agonists, and Relationship to Trafficking of Receptor Signaling
Mol. Pharmacol., September 1, 2002; 62(3): 590 - 601.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics